Brazil - Tiếng Bồ Đào Nha - ANVISA (Agência Nacional de Vigilância Sanitária)

ems sigma pharma ltda - desloratadina - anti-histaminicos sistemicos

Brazil - Tiếng Bồ Đào Nha - ANVISA (Agência Nacional de Vigilância Sanitária)

ems sigma pharma ltda - topiramato - anticonvulsivantes

Brazil - Tiếng Bồ Đào Nha - ANVISA (Agência Nacional de Vigilância Sanitária)

ems sigma pharma ltda - antimicoticos para uso topico

Áo - Tiếng Đức - AGES (Agentur für Gesundheit und Ernährungssicherheit)

sigmapharm arzneimittel gmbh & co kg - herba absinthii (auszug),aurantii amari epicarpii et mesocarpii (auszug),radix gentianae (auszug),dexpanthenol,flos matricariae (auszug),cortex condurango (auszug),radix liquiritiae (auszug) - appetite stimulants

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; rice starch; lactose monohydrate; oxidised maize starch; hydrolysed maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 0.0625 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; rice starch; magnesium stearate; hydrolysed maize starch; povidone; indigo carmine; oxidised maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Mexico - Tiếng Tây Ban Nha - myHealthbox

bayer ag -

Ai Cập - Tiếng Anh - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - powder for oral suspension - 250 mg/5ml

Ai Cập - Tiếng Anh - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - coated tablet - 375 mg

Ai Cập - Tiếng Anh - EDA (Egyptian Drug Authority)

sigma pharmaceutical industries - tablet - 3 mg